©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2022; 28(31): 4471-4474
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4471
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4471
Promising role of D-amino acids in irritable bowel syndrome
Yuka Ikeda, Kurumi Taniguchi, Haruka Sawamura, Ai Tsuji, Satoru Matsuda, Department of Food Science and Nutrition, Nara Women's University, Nara 630-8506, Japan
Author contributions: Ikeda Y and Matsuda S contributed equally to this work; Ikeda Y, Taniguchi K, Sawamura H, Tsuji A, and Matsuda S designed the research study and wrote the manuscript; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
Corresponding author: Satoru Matsuda, MD, PhD, Professor, Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan.
Received: April 4, 2022
Peer-review started: April 4, 2022
First decision: May 29, 2022
Revised: June 14, 2022
Accepted: July 20, 2022
Article in press: July 20, 2022
Published online: August 21, 2022
Processing time: 134 Days and 8.1 Hours
Peer-review started: April 4, 2022
First decision: May 29, 2022
Revised: June 14, 2022
Accepted: July 20, 2022
Article in press: July 20, 2022
Published online: August 21, 2022
Processing time: 134 Days and 8.1 Hours
Core Tip
Core Tip: The potential efficacy of D-amino acids for the treatment of irritable bowel syndrome is shown here.